HLS Therapeutics Announces Promotional Agreement with Pfizer for Vascepa® in Canada

Retrieved on: 2021-08-16 10:30:00

Tags for this article:

Health sciences

Life Sciences

Articles

Amarin Corporation

Forward-looking statement

Pfizer

Cardiovascular disease

Pharmaceutical industry

Ethyl eicosapentaenoic acid

icosapent ethyl

Pfizer Inc.

HLS Therapeutics Inc.

Click the tags to see associated articles and topics

HLS Therapeutics Announces Promotional Agreement with Pfizer for Vascepa® in Canada. View article details on HISWAI: https://finance.yahoo.com/news/hls-therapeutics-announces-promotional-agreement-103000534.html

Excerpt

16, 2021 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: ... HLS in-licensed the exclusive rights to Vascepa for the Canadian market ... What the Afghan government's collapse might mean for the U.S. stock market.

Article found on: finance.yahoo.com

View Original Article